Still et al developed the DiaRem score to predict the chances that a patient will have remission from Type 2 diabetes following Roux-en-Y gastric bypass (RYGB) surgery. The authors are from Geisinger Health System, Scottsdale Healthcare Bariatric Center in Scottsdale, University of Arizona and Pennsylvania State University.
